Merck KGaA ١ مايو ٢٠٢٦ Merck KGaA Backs Hybrid Cancer Drugs And Greener Lab Consumables - simplywall.st
Merck KGaA ١ مايو ٢٠٢٦ Merck KGaA doses first patient in Phase III programme of enpatoran - Clinical Trials Arena
Merck KGaA ٢٨ أبريل ٢٠٢٦ Remepy, Merck KGaA pair up to test app-paired drug model in rare tumour - FirstWord Pharma
Merck KGaA ٢٨ أبريل ٢٠٢٦ Merck KGaA and Remepy join forces to develop combo drug-digital therapies - Medical Device Network
Merck KGaA ٢٧ أبريل ٢٠٢٦ Merck KGaA: Small Breakout In 2026, Followed By Normalization (OTCMKTS:MKGAF) - Seeking Alpha
Merck KGaA ١ أبريل ٢٠٢٦ Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business - Merck Group